Bharat Biotech prices its nasal vaccine at ₹800 for private markets and ₹325 for governments – The Hindu

iNCOVACC is the world’s first intranasal COVID-19 vaccine to receive approval for the primary two-dose schedule as well as a heterologous booster dose